Pearl Second Opinion

Pearl Inc. is a dental AI company with a mailing address in West Hollywood, California, and Ophir Tanz named as CEO and founder. The website does not state a founding year. It serves dentists, DSOs and universities and claims more than 29,000 practices.

Second Opinion detects pathologies in 2D x-rays and Second Opinion 3D reviews CBCT scans with AI segmentation, a 3D viewer and an embedded request for a radiologist report. Further modules cover practice intelligence, revenue cycle management, clinical training and Pearl Voice for clinical notes and perio charting. The site claims 40+ integrations and availability in 120+ countries.

• Second Opinion: AI detection of pathologies on 2D x-rays.
• Second Opinion 3D: CBCT segmentation, 3D viewer and radiologist report request.
• Practice Intelligence: practice data turned into growth and care insights.
• RCM: insurance verification through claim submission.
• Calibrate: AI-guided clinical training.
• Pearl Voice: ambient clinical notes and perio charting.

Dental chains in Vietnam can use AI second reads on radiographs to support dentist decisions. Dental universities can use training modules. Implant clinics can review CBCT scans with 3D segmentation.

Color-coded findings support patient communication, with a claimed 30 percent higher treatment acceptance. Integrations with practice and imaging software such as Open Dental and Dentrix Ascend limit workflow changes. FDA-cleared tools for both 2D and 3D imaging are listed. Claim-ready documentation supports insurance submissions.

Radiograph AI is moving from 2D x-rays into CBCT and bundled revenue tools. Pearl states availability in 120+ countries, while some 3D features await regulatory approval outside Canada, so regional approval remains a factor for Vietnam.

Pearl Inc., West Hollywood, California. Second Opinion 3D commercial launch 3 September 2026; pathology detection in 3D available only in Canada pending other approvals. Cites 26+ FDA clearances and an MDSAP logo.